Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P43026 (lipopolysaccharide)
 62,215 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Interleukin-1 (IL-1) plays a major role in inflammatory responses. Activation of coagulation and fibrin deposition typical of these reactions is mediated by macrophage procoagulants induced on stimulated macrophages. IL-1 activity in the supernatant of lipopolysaccharide (LPS)-stimulated guinea-pig macrophages was markedly enhanced by the presence of thrombin during macrophage activation. Although thrombin alone had no effect, inclusion of 1 mU/ml of thrombin with suboptimal levels of LPS produced a 200-fold increase in IL-1 activity, and further enhancement was observed with increasing doses of thrombin. The active site of thrombin was necessary for enhancement, as the serine esterase inhibitor di-isopropyl-fluorophosphate (DIP) and hirudin inhibited the synergy observed with LPS and thrombin. Prothrombin and Factor Xa also enhanced IL-1 production, although not to the same extent as thrombin. Factor Xa-like activity was demonstrated on the surface of LPS-stimulated macrophages. Both the Xa-like activity and IL-1 generated by LPS-stimulated cells were inhibited by heparin. Heparin with a high affinity for antithrombin III (anti-coagulant heparin; HAH) inhibited IL-1 generation, whereas low-affinity heparin (non-anticoagulant; LAH) had no effect. We show that proteases of the extrinsic coagulation cascade enhance IL-1 generation and propose that a Factor Xa-like activity present in activated macrophages, together with thrombin, may be important in IL-1 processing.
 ...
PMID:Thrombin and factor Xa enhance the production of interleukin-1. 222 24

Thioglycollate-induced peritoneal exudate cells (TG-PEC) developed increased procoagulant activity after incubation with lymphokine and lipopolysaccharide (LPS). Dilutions of up to 1/1000 for insoluble Con A and 1/200 for periodate-induced lymphokine supernatants were active in enhancing macrophage procoagulant activity (MPCA), which was detected after a 2-hr incubation period and steadily increased over 20 hr. MPCA could also be induced by antigen; peritoneal cells from sensitized B6AF1 mice with strong footpad reactions to ovalbumin (OVA) responded to as little as 0.1 microgram/ml OVA in the MPCA test in an antigen-specific manner. By contrast, PEC from sensitized CBA/J mice that gave poor in vivo responses to OVA only reacted with high concentrations of the antigen in vitro. Production of the lymphokine responsible for induction of MPCA required an Ly-1+2- T cell, a nylon wool-adherent cell, and an la-17-bearing adherent cell. The MPCA induced by lymphokine or LPS did not appear to be a serine esterase and was not inhibited by phospholipase C. Coagulation of human factor-deficient plasma with activated TG-PEC indicated a requirement for Factor X.
 ...
PMID:Macrophage procoagulant activity as a measure of cell-mediated immunity in the mouse. 618 99

A long-term suspension culture line (c-WRT-7) was successfully established from a transplantable myelomonocytic leukemia induced by a neonatal injection of Rauscher leukemia virus in a WKA/Hok rat. A c-WRT-7 cell line was capable of being transplanted into syngeneic rats, and when transplanted, increased numbers of macrophage-like cells were observed in the peripheral blood of rats after i.v. injection. In in vitro culture, about 10% of the c-WRT-7 cells naturally differentiated into macrophage-like cells, which adhered to the bottom of a culture flask, and also possessed phagocytic activity. By means of cytological examination, about 30% of the c-WRT-7 cells were observed to be monoblastic with alpha-naphthyl butyrate esterase activity. The nature of these c-WRT-7 cells as a myelomonocytic leukemia line was constant during in vitro passages of more than 30 generations. In vitro treatment of c-WRT-7 cells with lipopolysaccharide, 12-O-tetradecanoylphorbol-13-acetate, or retinoic acid increased the numbers of differentiated cells with phagocytic activity to 80%. Treatment of the c-WRT-7 cells with the inducers also induced 15 to 20% of the cells to differentiate into metamyelocytes and segmented neutrophils. The Fc receptor and the complement receptor both became detectable on the surface of c-WRT-7 cells after treatment with lipopolysaccharide, 12-O-tetradecanoylphorbol-13-acetate, or retinoic acid. However, rosette-forming activity of sheep erythrocytes pretreated with neuraminidase which has been known as a marker of normal rat macrophages was not induced in c-WRT-7 cells. This shows that differentiated leukemic cells are not exactly identical with normal macrophages.
 ...
PMID:Establishment and characterization of a differentiating myeloid cell line obtained from a rat myelomonocytic leukemia. 657 57

We have examined the mechanism of release of monocyte-derived mediators that stimulate fibroblast proliferation in vitro. Adherence of human monocytes promotes the rapid release of these factors and treatment of adherent peripheral blood mononuclear cell (APBM) cultures with lipopolysaccharide (LPS) greatly enhances the level of fibroblast-stimulating activity in the cell-free culture supernatant fluid (SN). Stimulation of phagocytosis or pinocytosis does not alter the release of these mediators from APBM cultures while trypan blue pretreatment of peripheral blood mononuclear cells (PBM) results in a significant reduction in fibroblast stimulation by PBM-SN. Protein synthesis was blocked by pretreatment of monocytes with puromycin and was accompanied by a concomitant reduction in the production of these mediators. Monocyte serine proteases appear to be essential for mediator synthesis or release since tosyl-lysine chloromethyl ketone (TLCK) and phenylmethyl sulfonyl fluoride (PMSF), irreversible inhibitors of serine esterase activity, diminish the release of fibroblast-stimulating factors. Furthermore, time course data indicate that monocytes rapidly release these products in vitro during the first 24 hr of culture with significantly reduced levels being produced from 24 to 96 hr. These data indicate that adherent human monocytes rapidly release fibroblast-activating mediators in vitro, requiring both protein synthesis and protease activity; furthermore LPS, but not phagocytosis, can enhance the release of these products.
 ...
PMID:Characterization of the release of human monocyte regulators of fibroblast proliferation. 710 71

We present reference maps of the mouse serum proteome (run under reducing and non-reducing conditions), from control animals, from mice injected with lipopolysaccharide (LPS) to induce systemic inflammation, and from mice transgenic for human apolipoproteins A-I and A-II. Seventy-seven spots/spot chains from the reducing gels were identified by HPLC MS/MS, representing 28 distinct proteins, including a species-specific protease inhibitor, contrapsin, and high levels of carboxylesterase. The concentrations of acute-phase reactants were monitored for 96 h after LPS challenge. The greatest changes (four-fold 48 h after LPS administration) were observed for haptoglobin and hemopexin. Orosomucoid/alpha(1)-acid glycoprotein and apolipoprotein A-I increased steadily, to 50-60% above baseline at 96 h from stimulation. In mice transgenic for human apolipoprotein A-I the levels of expression of orosomucoid/alpha(1)-acid glycoprotein, alpha(1)-macroglobulin, esterase, kininogen and contrapsin were altered compared to knockout mice lacking apolipoprotein A-I. In contrast, except for the presence of apolipoprotein A-II, no statistically significant difference was observed in mice transgenic for human apolipoprotein A-II.
 ...
PMID:Reference maps of mouse serum acute-phase proteins: changes with LPS-induced inflammation and apolipoprotein A-I and A-II transgenes. 1619 95

Endocannabinoid-metabolizing enzymes are downregulated in response to lipopolysaccharide (LPS)-induced inflammation in mice, which may serve as a negative feedback mechanism to increase endocannabinoid levels and reduce inflammation. Increased plasma levels of the pro-inflammatory cytokine interleukin-6 (IL-6) and decreased fatty acid amide hydrolase (FAAH) activity in peripheral lymphocytes from individuals diagnosed with Huntington's disease (HD) suggests that a similar negative feedback system between inflammation and the endocannabinoid system operates in humans. We investigated whether CpG- (unmethylated bacterial DNA) and LPS-induced IL-6 levels in peripheral blood mononuclear cells (PBMCs) from non-HD and HD individuals modulated the activities of endocannabinoid hydrolases monoacylglycerol lipase (MAGL) and carboxylesterase (CES). Baseline plasma IL-6 levels and 2-arachidonoylglycerol (2-AG) hydrolytic activity in PBMC lysates were not different in HD and non-HD individuals. Inhibition of MAGL and CES1 activity in PBMCs using the inhibitors JZL184 and WWL113, respectively, demonstrated that MAGL was the dominant 2-AG hydrolytic enzyme in PBMCs, regardless of disease state. Correlative analyses of 2-AG hydrolytic activity versus enzyme abundance confirmed this conclusion. Flow cytometric analysis of PBMCs showed that MAGL and CES1 were primarily expressed in monocytes and to a lesser extent in lymphocytes. In conclusion, these data suggest that IL-6 did not influence 2-AG hydrolytic activity in human PBMCs; however, monocytic MAGL was shown to be the predominant 2-AG hydrolytic enzyme.
 ...
PMID:Characterization of Endocannabinoid-Metabolizing Enzymes in Human Peripheral Blood Mononuclear Cells under Inflammatory Conditions. 3051 53